Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients ...

Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...

including 1,000 roles at the company. Novartis' announcement comes after President Donald Trump earlier this week said his ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

Drugmakers, including Lilly, Novartis, and Johnson & Johnson, are already committing to increasing their U.S. manufacturing ...